3-dimethylamino-1-[(4-imidazol-1-yl)phenyl]propen-1-one | 314268-64-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-dimethylamino-1-[(4-imidazol-1-yl)phenyl]propen-1-one
• 英文别名: 3-(dimethylamino)-1-(4-imidazol-1-ylphenyl)prop-2-en-1-one
• CAS: 314268-64-9
• 化学式: C₁₄H₁₅N₃O
• mdl: MFCD00138184
• 分子量: 241.293
• InChiKey: FXWWXRGTJRQUCF-UHFFFAOYSA-N

物化性质

• 沸点：
  405.0±45.0 °C(Predicted)
• 密度：
  1.08±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  38.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-dimethylamino-1-[(4-imidazol-1-yl)phenyl]propen-1-one 、 6-Guanidinobenzothiazole nitrate 在 sodium hydroxide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-[4-(4-imidazol-1-ylphenyl)pyrimidin-2-yl]-1,3-benzothiazol-6-amine
  参考文献：
  名称：

  Synthesis and structure–activity relationship of aminopyrimidine IKK2 inhibitors

  摘要：

  The synthesis and structure-activity relationship of a novel series of aminopyrimidines are exemplified. Results of key compounds from within this series in the E-selectin reporter cell assay are also reported. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.04.062
• 作为产物：
  描述：

  N,N-二甲基甲酰胺二甲基缩醛 、 4-咪唑乙酰苯酮 生成 3-dimethylamino-1-[(4-imidazol-1-yl)phenyl]propen-1-one
  参考文献：
  名称：

  Synthesis and structure–activity relationship of aminopyrimidine IKK2 inhibitors

  摘要：

  The synthesis and structure-activity relationship of a novel series of aminopyrimidines are exemplified. Results of key compounds from within this series in the E-selectin reporter cell assay are also reported. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.04.062

文献信息

• 5-cyano-2-aminopyrimidine derivatives
  申请人：——

  公开号：US20020147339A1

  公开（公告）日：2002-10-10

  Pyrimidines of formula (1) are described 1 wherein Ar is an optionally substituted aromatic or heteroaromatic group; R 1 is a hydrogen atom or a straight or branched chain alkyl group; R 2 is a —X 1 —R 3 group where X 1 is a direct bond or a linker atom or group, and R 3 is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are selective KDR Kinase and/or FGFr Kinase inhibitors and are of use in the prophylaxis and treatment of disease states associated with angiogenesis.

  公式（1）中描述了嘧啶类化合物，其中Ar是可选择取代的芳香或杂芳基团；R1是氢原子或直链或支链烷基基团；R2是一个—X1—R3基团，其中X1是直接键或连接原子或基团，而R3是可选择取代的脂肪、环脂肪、杂原子脂肪、杂环脂肪、芳香或杂芳基团；以及它们的盐、溶剂合物、水合物和N-氧化物。这些化合物是选择性的KDR激酶和/或FGFr激酶抑制剂，并可用于预防和治疗与血管生成相关的疾病状态。
• 5-Cyano-2-aminopyrimidine derivatives
  申请人：Celltech R&D Limtied

  公开号：US20040180914A1

  公开（公告）日：2004-09-16

  Pyrimidines of formula (1) are described 1 wherein Ar is an optionally substituted aromatic or heteroaromatic group; R 1 is a hydrogen atom or a straight or branched chain alkyl group; R 2 is a —X 1 —R 3 group where X 1 is a direct bond or a linker atom or group, and R 3 is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are selective KDR Kinase and/or FGFr Kinase inhibitors and are of use in the prophylaxis and treatment of disease states assoicated with angiogenesis.

  描述了化学式（1）的嘧啶类化合物，其中Ar是可选取代的芳香族或杂环芳香族基团；R1是氢原子或直链或支链烷基；R2是—X1—R3基团，其中X1是直接键或连接原子或基团，R3是可选取代的脂肪族、环状脂肪族、杂原子脂肪族、杂环脂肪族、芳香族或杂环芳香族基团；以及其盐、溶剂合物、水合物和N-氧化物。这些化合物是选择性KDR激酶和/或FGFr激酶抑制剂，可用于预防和治疗与血管生成相关的疾病状态。